An Open-Label Study to Evaluate the Safety and Efficacy of the Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Chronic Hepatitis C Virus Genotype 4 Infection in Egypt

Name: An Open-Label Study to Evaluate the Safety and Efficacy of the Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Chronic Hepatitis C Virus Genotype 4 Infection in Egypt
Creator: Vivli
Published: 2018-10-27T12:33:04+08:00

DataCite Commons2025-05-01 更新2026-05-07 收录

丙型肝炎临床试验

抗病毒药物疗效评估

数据链接：

https://search.vivli.org/doiLanding/studies/00003113/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

This study evaluates the efficacy and safety of ABT-450/r/ABT-267 with RBV in treatment-naive and treatment-experienced HCV GT4 subjects without or with compensated cirrhosis.

提供机构：

Vivli

创建时间：

2018-10-27